电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

Recombinant CA 19-9 抗体

CA 19-9 适用: 人 FACS, IF, IHC (p) 宿主: 兔 Monoclonal CA19-9-1390R unconjugated Recombinant Antibody
产品编号 ABIN4949235
发货至: 中国
  • 抗原 See all CA 19-9 抗体
    CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
    抗体类型
    Recombinant Antibody
    适用
    • 34
    • 1
    • 1
    宿主
    • 22
    • 14
    克隆类型
    • 32
    • 3
    单克隆
    标记
    • 19
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This CA 19-9 antibody is un-conjugated
    应用范围
    • 20
    • 14
    • 14
    • 13
    • 8
    • 5
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    Flow Cytometry (FACS), Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    纯化方法
    Protein A affinity
    免疫原
    Purified human protein used as the immunogen for the recombinant CA19-9 antibody.
    克隆位点
    CA19-9-1390R
    亚型
    IgG kappa
    Top Product
    Discover our top product CA 19-9 Primary Antibody
  • 应用备注
    Optimal dilution of the recombinant CA19-9 antibody should be determined by the researcher.

    1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 2-4 μg/million cells in 0.1ml,Immunofluorescence: 5-10 μg/mL,Immunohistochemistry (FFPE): 5-10 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)

    限制
    仅限研究用
  • 浓度
    1 mg/mL
    缓冲液
    1 mg/mL in 1X PBS, BSA free, sodium azide free
    储存液
    Azide free
    储存条件
    4 °C,-20 °C
    储存方法
    Store the recombinant CA19-9 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • 抗原
    CA 19-9 (Gastrointestinal Cancer Antigen CA19-9 (CA 19-9))
    别名
    CA19-9 (CA 19-9 产品)
    背景
    CA19-9, a carbohydrate epitope expressed on a high MW (>400  kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens.
You are here:
客服